Undisclosed Rare Disease Program

About Binacea Pharma

Binacea Pharma is a private, preclinical-stage biotech targeting oncology and rare diseases with a proprietary antibody platform. The company is advancing a pipeline of novel biologics, including a lead program for a rare autoimmune condition and an immuno-oncology candidate, positioning itself in high-need therapeutic areas. With a lean operational model and backing from venture capital investors, Binacea aims to achieve key preclinical milestones to advance programs toward clinical development and potential partnerships.

Therapeutic Areas